DNLI R&D Expense Growth
Denali Therapeutics Inc · R&D Expense Growth
DNLI R&D Expense Growth
Latest reported5.63%period ending
DNLI FY R&D Growth (YoY) (0.00% → 5.63%)
Latest values, visible window
High-resolution chart · PNG
DNLI r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 5.6346% | |
| -6.4726% | |
| 18.1595% | |
| 35.1905% | |
| 24.8045% | |
| 9.9456% | |
| 35.0593% | |
| 92.2952% | |
| -1.6406% | |
| 554.239% | |
| 0% |